These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption. de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085 [TBL] [Abstract][Full Text] [Related]
43. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH. Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234 [TBL] [Abstract][Full Text] [Related]
44. A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes. Rustanti L; Jin H; Lor M; Lin MH; Rawle DJ; Harrich D Virol J; 2017 Mar; 14(1):52. PubMed ID: 28288662 [TBL] [Abstract][Full Text] [Related]
45. Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: functional and pathogenic implications of genetic variation. Neogi U; Sood V; Banerjee S; Ghosh N; Verma S; Samrat S; Sharma Y; Saxena A; Husain S; Ramachandran VG; Das S; Sreedhar KV; Goel N; Wanchu A; Banerjea AC Indian J Exp Biol; 2009 Jun; 47(6):424-31. PubMed ID: 19634706 [TBL] [Abstract][Full Text] [Related]
46. Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Rao VR; Neogi U; Talboom JS; Padilla L; Rahman M; Fritz-French C; Gonzalez-Ramirez S; Verma A; Wood C; Ruprecht RM; Ranga U; Azim T; Joska J; Eugenin E; Shet A; Bimonte-Nelson H; Tyor WR; Prasad VR Retrovirology; 2013 Jun; 10():61. PubMed ID: 23758766 [TBL] [Abstract][Full Text] [Related]
47. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192 [TBL] [Abstract][Full Text] [Related]
48. Genetic and functional characterization of human immunodeficiency virus type 1 VprC variants from north India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the open reading frame of Vpr. Bano AS; Sood V; Neogi U; Goel N; Kuttiat VS; Wanchu A; Banerjea AC J Gen Virol; 2009 Nov; 90(Pt 11):2768-2776. PubMed ID: 19605589 [TBL] [Abstract][Full Text] [Related]
49. Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression. Dey SS; Xue Y; Joachimiak MP; Friedland GD; Burnett JC; Zhou Q; Arkin AP; Schaffer DV J Biol Chem; 2012 Mar; 287(11):7945-55. PubMed ID: 22253435 [TBL] [Abstract][Full Text] [Related]
50. Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties. Campbell GR; Senkaali D; Watkins J; Esquieu D; Opi S; Yirrell DL; Kaleebu P; Loret EP Vaccine; 2007 Dec; 25(50):8441-7. PubMed ID: 17997200 [TBL] [Abstract][Full Text] [Related]
51. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains. Bilodeau PS; Domsic JK; Stoltzfus CM J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286 [TBL] [Abstract][Full Text] [Related]
52. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Grégoire C; Péloponèse JM; Esquieu D; Opi S; Campbell G; Solomiac M; Lebrun E; Lebreton J; Loret EP Biopolymers; 2001; 62(6):324-35. PubMed ID: 11857271 [TBL] [Abstract][Full Text] [Related]
53. Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern India. Lata S; Ronsard L; Sood V; Dar SA; Ramachandran VG; Das S; Banerjea AC PLoS One; 2013; 8(12):e82128. PubMed ID: 24367500 [TBL] [Abstract][Full Text] [Related]
54. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat. Chakraborty S; Kabi M; Ranga U J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338 [TBL] [Abstract][Full Text] [Related]
55. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. Choi JY; Hightower GK; Wong JK; Heaton R; Woods S; Grant I; Marcotte TD; Ellis RJ; Letendre SL; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Richman DD; Smith DM; J Neurovirol; 2012 Apr; 18(2):81-90. PubMed ID: 22528397 [TBL] [Abstract][Full Text] [Related]
56. Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. Campbell GR; Watkins JD; Singh KK; Loret EP; Spector SA J Virol; 2007 Jun; 81(11):5919-28. PubMed ID: 17376903 [TBL] [Abstract][Full Text] [Related]
57. Genetic characterization analysis of the tat exon-1 region of HIV type 1 CRF07_BC strains in China. Fang Z; Xing H; Meng Z; Hong K; Liao L; He X; Shao Y AIDS Res Hum Retroviruses; 2010 Mar; 26(3):359-63. PubMed ID: 20334571 [TBL] [Abstract][Full Text] [Related]
58. Rev Protein Diversity in HIV-1 Group M Clades. Lebedev A; Kim K; Ozhmegova E; Antonova A; Kazennova E; Tumanov A; Kuznetsova A Viruses; 2024 May; 16(5):. PubMed ID: 38793640 [TBL] [Abstract][Full Text] [Related]
59. Overexpression of recombinant HIV-1 Subtype C Tat and Nef in a Salmonella vaccine vector. Chin'ombe N; Lebeko M; Kgatle M Pan Afr Med J; 2013; 16():19. PubMed ID: 24498468 [TBL] [Abstract][Full Text] [Related]
60. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. Meloni ST; Kim B; Sankalé JL; Hamel DJ; Tovanabutra S; Mboup S; McCutchan FE; Kanki PJ J Virol; 2004 Nov; 78(22):12438-45. PubMed ID: 15507630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]